Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Thulkar

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
The Indian Journal of Medical Research|September 10, 2019
High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcomeLalit Kumar, Dev Ramavath, Babita Kataria, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 22, 2022
Multiple Myeloma: Impact of Time to Transplant on the OutcomeLalit Kumar, Mohammad Mir Hussain, Rajegowda Chethan, et al.
Pediatric Blood & Cancer|July 22, 2021
Treating early-stage Hodgkin lymphoma in resource-limited settings: InPOG-HL-15-01 experienceAmita Mahajan, Manisha Singh, Sameer Bakhshi, et al.
Journal of Global Oncology|February 28, 2019
Primary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical SciencesMukesh Patekar, Narayan Adhikari, Ahitagni Biswas, et al.
Clinical Hematology International|October 1, 2021
Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple MyelomaLalit Kumar, Santosh Kumar Chellapuram, Ramavat Dev, et al.
Pediatric Blood & Cancer|August 14, 2024
Ewing sarcoma among children 5 years of age or younger: Is it a different disease?Chitrakshi Nagpal, Shuvadeep Ganguly, Archana Sasi, et al.
Leukemia & Lymphoma|November 23, 2022
Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcomeLalit Kumar, Ranjit Kumar Sahoo, Sudhir Kumar, et al.
Radiology|April 26, 2007
Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trialAjay Kumar, Deep Narayan Srivastava, Trinh Thi Minh Chau, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2019
Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trialAtul Sharma, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
The Indian Journal of Medical Research|September 10, 2019
High-dose chemotherapy followed by autologous stem cell transplant for multiple myeloma: Predictors of long-term outcomeLalit Kumar, Dev Ramavath, Babita Kataria, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 22, 2022
Multiple Myeloma: Impact of Time to Transplant on the OutcomeLalit Kumar, Mohammad Mir Hussain, Rajegowda Chethan, et al.
Pediatric Blood & Cancer|July 22, 2021
Treating early-stage Hodgkin lymphoma in resource-limited settings: InPOG-HL-15-01 experienceAmita Mahajan, Manisha Singh, Sameer Bakhshi, et al.
Journal of Global Oncology|February 28, 2019
Primary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical SciencesMukesh Patekar, Narayan Adhikari, Ahitagni Biswas, et al.
Clinical Hematology International|October 1, 2021
Induction Therapy with Novel Agents and Autologous Stem Cell Transplant Overcomes the Adverse Impact of Renal Impairment in Multiple MyelomaLalit Kumar, Santosh Kumar Chellapuram, Ramavat Dev, et al.
Pediatric Blood & Cancer|August 14, 2024
Ewing sarcoma among children 5 years of age or younger: Is it a different disease?Chitrakshi Nagpal, Shuvadeep Ganguly, Archana Sasi, et al.
Leukemia & Lymphoma|November 23, 2022
Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcomeLalit Kumar, Ranjit Kumar Sahoo, Sudhir Kumar, et al.
Radiology|April 26, 2007
Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trialAjay Kumar, Deep Narayan Srivastava, Trinh Thi Minh Chau, et al.
European Journal of Cancer (Oxford, England : 1990)|November 11, 2019
Modified gemcitabine and oxaliplatin or gemcitabine + cisplatin in unresectable gallbladder cancer: Results of a phase III randomised controlled trialAtul Sharma, Bidhu Kalyan Mohanti, Surendra Pal Chaudhary, et al.
Pageof 20